Key Capital COVID-19 Oral Pill Vaccine Update
Press release content from Accesswire. The AP news staff was not involved in its creation. Key Capital COVID-19 Oral Pill Vaccine Update December 28, 2020 GMT Key Capital Invites Partnering Inquiries for COVID-19 Therapeutic Vaccine NEW YORK, NY / ACCESSWIRE / December 28, 2020 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) advises that the Company, through Key Biotec, is offering an unique opportunity to major investors, institutions, and/or government agencies to partner a patent protected oral pill COVID-19 therapeutic vaccine that has been developed by the Immunitor scientific team, and subjec...
Source: apnews.com